Weiliang Song

846 total citations
18 papers, 183 citations indexed

About

Weiliang Song is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Weiliang Song has authored 18 papers receiving a total of 183 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Weiliang Song's work include CAR-T cell therapy research (9 papers), Circular RNAs in diseases (4 papers) and MicroRNA in disease regulation (4 papers). Weiliang Song is often cited by papers focused on CAR-T cell therapy research (9 papers), Circular RNAs in diseases (4 papers) and MicroRNA in disease regulation (4 papers). Weiliang Song collaborates with scholars based in China. Weiliang Song's co-authors include Zhuojun Ling, Biping Deng, Xiaoming Feng, Yue Tan, Yuzhuo Chen, Jiajia Duan, Alex H. Chang, Jing Pan, Jinlong Xu and Zelin Wang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Cellular and Molecular Medicine.

In The Last Decade

Weiliang Song

17 papers receiving 183 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiliang Song China 7 129 55 49 40 29 18 183
Lijuan Ding China 8 158 1.2× 45 0.8× 26 0.5× 38 0.9× 20 0.7× 24 227
Sandra Horowitz United States 5 104 0.8× 35 0.6× 44 0.9× 18 0.5× 12 0.4× 8 174
Martina Sersch China 7 154 1.2× 73 1.3× 33 0.7× 29 0.7× 38 1.3× 13 182
Haven R. Garber United States 9 162 1.3× 82 1.5× 42 0.9× 103 2.6× 25 0.9× 20 245
Walid Warda France 7 132 1.0× 82 1.5× 42 0.9× 61 1.5× 34 1.2× 8 222
Mengjun Zhong China 5 232 1.8× 56 1.0× 24 0.5× 153 3.8× 19 0.7× 5 273
Nils W. Engel Germany 6 178 1.4× 99 1.8× 63 1.3× 81 2.0× 32 1.1× 14 247
Rebecca Thomas United States 8 164 1.3× 112 2.0× 60 1.2× 35 0.9× 32 1.1× 13 261
Sarah Inglott United Kingdom 9 99 0.8× 92 1.7× 35 0.7× 48 1.2× 17 0.6× 15 237
J.T. Greene United States 6 93 0.7× 67 1.2× 24 0.5× 66 1.6× 14 0.5× 11 169

Countries citing papers authored by Weiliang Song

Since Specialization
Citations

This map shows the geographic impact of Weiliang Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiliang Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiliang Song more than expected).

Fields of papers citing papers by Weiliang Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiliang Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiliang Song. The network helps show where Weiliang Song may publish in the future.

Co-authorship network of co-authors of Weiliang Song

This figure shows the co-authorship network connecting the top 25 collaborators of Weiliang Song. A scholar is included among the top collaborators of Weiliang Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiliang Song. Weiliang Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Song, Weiliang, et al.. (2023). Circular RNA (circ)_0053277 Contributes to Colorectal Cancer Cell Growth, Angiogenesis, Metastasis and Glycolysis. Molecular Biotechnology. 66(11). 3285–3299. 5 indexed citations
2.
Zhang, Licheng, et al.. (2023). Circ_0084188 Regulates the progression of colorectal cancer through the miR-769-5p/KIF20A axis. Biochemical Genetics. 61(5). 1727–1744. 5 indexed citations
3.
Pan, Jing, Yue Tan, Guoling Wang, et al.. (2022). Updated efficacy and safety report of a phase I trial of donor-derived CD7 CAR T cells for T-cell acute lymphoblastic leukemia.. Journal of Clinical Oncology. 40(16_suppl). 7023–7023. 1 indexed citations
4.
Zhao, Liping, Jing Pan, Yue Tan, et al.. (2022). Autologous CD7-targeted CAR T-cell therapy for refractory or relapsed T-cell acute lymphoblastic leukemia/lymphoma.. Journal of Clinical Oncology. 40(16_suppl). 7035–7035. 10 indexed citations
5.
Pan, Jing, Yue Tan, Biping Deng, et al.. (2022). Phase I study of donor-derived CD5 CAR T cells in patients with relapsed or refractory T-cell acute lymphoblastic leukemia.. Journal of Clinical Oncology. 40(16_suppl). 7028–7028. 21 indexed citations
6.
Li, Jiaxing, et al.. (2022). Global COVID-19 Epidemic Prediction and Analysis Based on Improved Dynamic Transmission Rate Model with Neural Networks. Mathematical Problems in Engineering. 2022. 1–12. 1 indexed citations
7.
Tan, Yue, Jing Pan, Biping Deng, et al.. (2022). Efficacy and Safety of Donor-Derived CD7 CAR T Cells for r/r T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Interim Analysis from a Phase 2 Trial. Blood. 140(Supplement 1). 4602–4603. 5 indexed citations
9.
Tan, Yue, Biping Deng, Zhuojun Ling, et al.. (2021). Toxicity and effectiveness of CD19 CAR T therapy in children with high-burden central nervous system refractory B-ALL. Cancer Immunology Immunotherapy. 70(7). 1979–1993. 16 indexed citations
10.
Deng, Biping, Chuo Li, Weiliang Song, et al.. (2021). Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL. Frontiers in Oncology. 11. 640166–640166. 15 indexed citations
11.
Li, Minghao, et al.. (2021). Identification of circRNA circ-CSPP1 as a potent driver of colorectal cancer by directly targeting the miR-431/LASP1 axis. Open Life Sciences. 16(1). 523–536. 6 indexed citations
12.
Pan, Jing, Jing Pan, Biping Deng, et al.. (2021). Donor-derived CD7 CAR T cells for T-cell acute lymphoblastic leukemia.. Journal of Clinical Oncology. 39(15_suppl). 10001–10001. 2 indexed citations
13.
Pan, Jing, Biping Deng, Zhuojun Ling, et al.. (2020). Ruxolitinib mitigates steroid‐refractory CRS during CAR T therapy. Journal of Cellular and Molecular Medicine. 25(2). 1089–1099. 63 indexed citations
14.
Pan, Jing, Xiuwen Xu, Zhuojun Ling, et al.. (2019). Association of Genetic Factors with Long-Term Outcome in Refractory r/r B-ALL Patients after CAR T-Cell Therapy. Blood. 134(Supplement_1). 750–750. 4 indexed citations
15.
Chen, Yuzhuo & Weiliang Song. (2018). Wnt/catenin β1/microRNA 183 predicts recurrence and prognosis of patients with colorectal cancer. Oncology Letters. 15(4). 4451–4456. 15 indexed citations
16.
Song, Weiliang, et al.. (2015). Efficacy of FOLFOXIRI versus XELOXIRI plus bevacizumab in the treatment of metastatic colorectal cancer.. PubMed. 8(10). 18713–20. 5 indexed citations
17.
Song, Weiliang. (2000). The management of graft blood vessel in the living-related small bowel transplantation. Zhonghua putong waike zazhi. 1 indexed citations
18.
Song, Weiliang. (1998). Vibration analysis of spinning frame by using modal testing technique. Journal of Tsinghua University(Science and Technology).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026